BioMed Research International / 2009 / Article / Tab 3

Research Article

Benefit of Whole Pelvic Radiotherapy Combined with Neoadjuvant Androgen Deprivation for the High-Risk Prostate Cancer

Table 3

Univariate and multivariate analysis of clinical and treatment factors predicting for cause specific survival ( ).

Factor Hazard ratio (95% confidence interval)
Univariate*Multivariate

WPRT + N-ADT versus PORT.01.032.4 (1.5–3.1)
Age ( 70 versus 70).23
PSA level ( 30 versus 30).09
T stage (T2c versus T3).1
Gleason score (2–7 versus 8–10).02.041.3 (1.08–2.5)
% + ( 30 versus 30).001.032.1 (1.4–2.2)

WPRT: whole pelvic radiotherapy, N-ADT: neoadjuvant androgen deprivation therapy, PORT: prostate radiotherapy only, PSA: prostatic specific antigen, % +: probability of metastases to pelvic lymph nodes calculated according to the Roach formula [18].
*Kaplan-Meier analysis log-rank -value.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.